NKTR
Nektar Therapeutics
Clinical-stage biotechnology company focused on developing innovative medicines in immunotherapy
CUSIP: 640268108HealthcareUS1 holder
Total Value
$25.83M
Total Shares
4.79M
Net Share Change
-1.03M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$25.83M4.79M shares
TRIM-1.03M(-17.7%)